Fiona Cornel

Ms. Cornel is the Acting Manager of the Monoclonal Antibodies Division-Oncology (OMAD) of the Biologics and Radiopharmaceutical Drugs Directorate at Health Canada. She earned her MSc in Biology at Queen’s University in 1994 and joined the BRDD soon after as a research Biologist, where she participated in a number of diverse research projects focussed on biological drugs. In 2011, Fiona transitioned from research to the evaluation of the chemistry, manufacturing, and controls of various biotherapeutic products including monoclonal antibodies, hormones, enzymes, and cytokines. In 2020, she moved to a manager role in OMAD, which is responsible for the quality evaluation of biotherapeutics.